PTC Therapeutics | PTCT - EPS Earnings Per Share


PTC Therapeutics reported $0.92 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.27 0.20 Oct/22
FY2026Q2 Jun/2026 0.92 0.32 -0.83 Jul/30
FY2026Q1 Mar/2026 -0.03 -0.43 10.04 May/07
FY2025Q4 Dec/2025 -1.67 -0.47 -0.85 Feb/19
FY2025Q3 Sep/2025 0.20 -1.02 -1.39 Nov/04




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
Daiichi Sankyo JPY 37.72 11.03 Jun/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD -6.75 8.78 Jun/2026
Incyte USD 3.09 1.28 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Ironwood Pharmaceuticals USD 0.24 0.25 Mar/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD 0.92 0.95 Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
TG Therapeutics USD 0.05 0.07 Jun/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026
Xencor USD -1.71 1.62 Mar/2026